Abstract
Within the context of the COVID-19 pandemic, CO2 sensors that measure ventilation conditions and thereby reduce the risk of airborne infection, are gaining increasing attention. We investigated and verified the accuracy of 12 relatively low-cost sensor models that retail for less than $45 and are advertised as infection control measures on a major e-commerce site. Our results indicate that 25% of the tested sensors can be used to identify trends in CO2 concentration, if correctly calibrated. However, 67% of sensors did not respond to the presence of CO2, which suggests that a type of pseudo-technique is used to display the CO2 concentration. We recommend that these sensors are not suitable for infection prevention purposes. Furthermore, 58% of the investigated sensors showed significant responses to the presence of alcohol. Owing to the widespread use of alcohol in preventing the spread of infectious diseases, sensors that react to alcohol can display inaccurate values, resulting in inappropriate ventilation behavior. Therefore, we strongly recommended that these sensors not be used. Based on our results, we offer practical recommendations to the average consumer, who does not have special measuring equipment, on how to identify inaccurate CO2 sensors.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study was approved by the Ethics Committee on Experiments on Human Subjects (approval number of 21005), The University of Electro-communications, located at Chofugaoka 1-5-1, Chofu, Tokyo, Japan.
Funding Statement
This work was supported by the Research Grant Program of the KDDI Foundation. In addition, some of the data acquisition technologies in this study are based on results obtained from a project commissioned by the New Energy and Industrial Technology Development Organization (NEDO).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the following ethics committee. The approval number is 21005. The official name and location of the committee is 'Ethics Committee on Experiments on Human Subjects, The University of Electro-communications, Chofugaoka 1-5-1, Chofu, Tokyo, Japan'. The members of the committee are as follows: <Members' Directory> Director Sadao Obana; Professor Yutaka Kano, Chairman; Professor Hiroyui Kajimoto, Deputy Chairperson; Professor Akihiro Kashihara; Professor Akira Orimo, M.D., External committee member, School of Medicine, Juntendo University; Professor Takashi Yokoi, External committee member, Faculty of Human Sciences and Design, Japan Women's University; Akio Hamani, Esq., External committee member, Corporation lawyer; Accociate Professor Shinobu Tsurugano,M.D., Health Care Cener; Accociate Professor Soichi Ando; Accociate Professor Tetsuro Funato; Accociate Professor Kazuyuki Mito; Accociate Professor Guanghao Sun. All researchers at the University of Electro-Communications adhere to the Research Ethics Guidelines (ex. https://www.uec.ac.jp/about/activity/fraud_prevention/pdf/leaflet_e.pdf) and have submitted a written pledge (ex. https://www.uec.ac.jp/about/activity/fraud_prevention/pdf/seiyakusyo_e.pdf).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of competing financial interests (CFI):
The authors indicate no conflicts of interest.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.